Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
VERONA PHARMA PLC - ADR
About VRNA
Verona Pharma plc is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of chronic respiratory diseases with unmet medical needs. Ohtuvayre (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD) that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. The Company has evaluated nebulized Ohtuvayre in its Phase III clinical program ENHANCE (Ensifentrine as an Inhaled Nebulized COPD therapy) for COPD maintenance treatment. It has developed formulations of ensifentrine for the three inhalation devices: nebulizer, dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). Ensifentrine has potential in other respiratory diseases such as non-cystic fibrosis bronchiectasis. The Company's subsidiaries include Verona Pharma, Inc. and Verona Pharma Ireland Limited.
Find out what a historical investment in VERONA PHARMA PLC - ADR would be worth today using our VRNA stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy VRNA shares in Australia?
Buying VRNA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in VERONA PHARMA PLC - ADR in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VRNA
What is the ticker symbol of VERONA PHARMA PLC - ADR?
The ticker symbol for VERONA PHARMA PLC - ADR is VRNA.
How much is one share of VRNA?
One share of VRNA is valued at $106.91 as of 21 May 2026.
What is the market capitalisation of VERONA PHARMA PLC - ADR VRNA?
As of 21 May 2026 VERONA PHARMA PLC - ADR has a market cap of -.
What is the 52-week high for VERONA PHARMA PLC - ADR stock?
The VERONA PHARMA PLC - ADR 52-week high stock price is $NaN.
What is the 52-week low for VERONA PHARMA PLC - ADR stock?
The VERONA PHARMA PLC - ADR 52-week low stock price is $NaN.
Can I buy VRNA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VRNA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VRNA on Stake
- Buy VRNA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of VRNA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
VRNA related stocks